GABRIEL INSTITUTE INC

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2007

Legal Domicile

Principal Officer

STANLEY STEARNS

Phone

7136889345

Tax Period

2024-01-01 to 2024-12-31

GABRIEL INSTITUTE INC, founded in 2007, is a micro nonprofit in the Health Care sector that reported $30K in total revenue in fiscal year 2024. Expenses of $39K exceeded revenue, resulting in a 30% operating deficit.

Mission

TO CONDUCT RESEARCH AND PERFORM COLLABORATIVE RESEARCH WITH OTHER RESEARCH ORGANIZATIONS THAT HAVE A COMMON GOAL OF FINDING TREATMENTS AND CURES FOR OSTEOSARCOMA IN HUMAN AND ANIMALS AND TO PARTICIPATE IN TREATMENT FOR PEDIATRIC BONE CANCER AT TEXAS CHILDREN'S HOSPITAL

Program Service Accomplishments

Program 1

Expenses: $39,044

THE GABRIEL INSTITUTE, INC HAS DEVELOPED A MICRO DRILLING DEVICE FOR DRILLING THROUGH THE INSIDE OF A 22G NEEDLE. THIS IS BEING USED IN CONJUCTION WITH RADIATION SHIELDED MICROSYRINGES FOR THE...

THE GABRIEL INSTITUTE, INC HAS DEVELOPED A MICRO DRILLING DEVICE FOR DRILLING THROUGH THE INSIDE OF A 22G NEEDLE. THIS IS BEING USED IN CONJUCTION WITH RADIATION SHIELDED MICROSYRINGES FOR THE DELIVERY OF MICROLITER QUANTITIES OF SHORT HALF-LIFE BETA EMITTING RADIOISOTOPES DIRECTLY TO TUMORS. AT ISOTHERAPEUTICS GROUP THE TREATMENT METHOD AND TOOLS WERE FIRST UTILIZED ON LABORATORY ANIMALS, SPRAGUE DAWLEY RATS, TO PROVE THAT THE ISOTOPES REMAINED IN THE INJECTION SITE. LATER LABORATORY RATS WITH XENOGRAFTED TUMOR CELLS WERE TREATED WITH THE INJECTION METHOD TO PROVE EFFICACY OF THE TECHNIQUE. AFTER THE SUCCESSFUL RAT RESULTS, TREATMENT WAS BEGUN ON DOGS WITH SPONTANEOUS BONE TUMORS, FIRST AT ISOTHERAPEUTICS, THEN AT THE UNIVERSITY OF MISSOURI, AND THE TEXAS INSTITUTE FOR PRECLINICAL STUDIES (TEXAS A&M).

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2024)

Revenue Breakdown

Contributions & Grants $30,000

Program Service Revenue $0

Investment Income $0

Other Revenue $0

TOTAL REVENUE $30,000

Expense Breakdown

Grants Paid $0

Salaries & Benefits $0

Fundraising Expenses $0

Program Expenses $39,044

Other Expenses $39,044

TOTAL EXPENSES $39,044

Year-over-Year Comparison

	2024	2023	Change
Revenue	$30,000	N/A	N/A
Expenses	$39,044	$39,918	0.0%
Net Income	$-9,044	$-39,918	-0.8%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

N/A

Volunteers

N/A

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

⚠ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

$229,024

Total Directors